Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lafleur

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal for Immunotherapy of Cancer|September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesBrett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Determinants of <i>de novo</i> B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
Nature Immunology|May 27, 2025
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposureTyler J Ripperger, Jennifer L Uhrlaub, Makiko Watanabe, et al.
Immunity|November 1, 2020
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral ImmunityTyler J Ripperger, Jennifer L Uhrlaub, Makiko Watanabe, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal for Immunotherapy of Cancer|September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesBrett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Determinants of <i>de novo</i> B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
Nature Immunology|May 27, 2025
Intrinsic immunogenicity is a major determinant of type-specific responses in SARS-CoV-2 infectionsGrace E Quirk, Marta V Schoenle, Kameron L Peyton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2022
Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B CellsPeter H Goff, Laura Riolobos, Bonnie J LaFleur, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposureTyler J Ripperger, Jennifer L Uhrlaub, Makiko Watanabe, et al.
Immunity|November 1, 2020
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral ImmunityTyler J Ripperger, Jennifer L Uhrlaub, Makiko Watanabe, et al.
Pageof 10